Complex Generic Approval Delays Getting Congressional Attention
Executive Summary
US Energy and Commerce Committee leaders request data on complex generic approvals, guidances, saying additional changes may be needed for faster approvals.
You may also be interested in...
FDA Looks Ahead To Complex Product-Specific Guidances
The agency offers a glimpse of its regulatory agenda, although several have been carried over through multiple list updates.
Exploring the US FDA's Upcoming Complex Generic Product-Specific Guidance Lists
The agency offers a glimpse of its regulatory agenda, although several have been carried over through multiple list updates.
FDA Eyes Adverse Events For Mylan's Wixela Inhub
As patients log device complaints for Mylan’s Advair Diskus generic Wixela Inhub, the agency is assessing whether additional reminders about the products’ differences are needed.